Similar articles for PMID: 22367770

Year	Number of Results
1949	1
1970	1
1971	1
1993	2
1994	1
1997	1
1998	2
1999	1
2000	1
2001	1
2002	1
2003	3
2004	6
2005	5
2006	7
2007	10
2008	7
2009	11
2010	14
2011	10
2012	13
2013	11
2014	24
2015	16
2016	15
2017	23
2018	22
2019	24
2020	19
2021	19
2022	18
2023	4
2024	0

1

Allocating scarce financial resources for HIV treatment: benchmarking prices of antiretroviral medicines in Latin America.

Wirtz VJ, Santa-Ana-Tellez Y, Trout CH, Kaplan WA. Wirtz VJ, et al. Health Policy Plan. 2012 Dec;27(8):638-48. doi: 10.1093/heapol/czs011. Epub 2012 Feb 24. Health Policy Plan. 2012. PMID: 22367770

2

Factors influencing global antiretroviral procurement prices.

Wirtz VJ, Forsythe S, Valencia-Mendoza A, Bautista-Arredondo S. Wirtz VJ, et al. BMC Public Health. 2009 Nov 18;9 Suppl 1(Suppl 1):S6. doi: 10.1186/1471-2458-9-S1-S6. BMC Public Health. 2009. PMID: 19922690 Free PMC article.

3

An analysis of volumes, prices and pricing trends of the pediatric antiretroviral market in developing countries from 2004 to 2012.

Lee JSF, Sagaon Teyssier L, Dongmo Nguimfack B, Collins IJ, Lallemant M, Perriens J, Moatti JP. Lee JSF, et al. BMC Pediatr. 2016 Mar 15;16:41. doi: 10.1186/s12887-016-0578-x. BMC Pediatr. 2016. PMID: 26979974 Free PMC article.

4

Do national drug policies influence antiretroviral drug prices? Evidence from the Southern African Development community.

Liu Y, Galárraga O. Liu Y, et al. Health Policy Plan. 2017 Mar 1;32(2):170-177. doi: 10.1093/heapol/czw107. Health Policy Plan. 2017. PMID: 28207060 Free PMC article.

5

Reforming antiretroviral price negotiations and public procurement: the Mexican experience.

Adesina A, Wirtz VJ, Dratler S. Adesina A, et al. Health Policy Plan. 2013 Jan;28(1):1-10. doi: 10.1093/heapol/czs015. Epub 2012 Feb 28. Health Policy Plan. 2013. PMID: 22375026

6

Evolution of antiretroviral drug costs in Brazil in the context of free and universal access to AIDS treatment.

Nunn AS, Fonseca EM, Bastos FI, Gruskin S, Salomon JA. Nunn AS, et al. PLoS Med. 2007 Nov 13;4(11):e305. doi: 10.1371/journal.pmed.0040305. PLoS Med. 2007. PMID: 18001145 Free PMC article.

7

Negotiating antiretroviral drug prices: the experience of the Andean countries.

Seoane-Vazquez E, Rodriguez-Monguio R. Seoane-Vazquez E, et al. Health Policy Plan. 2007 Mar;22(2):63-72. doi: 10.1093/heapol/czl039. Epub 2007 Feb 13. Health Policy Plan. 2007. PMID: 17299024

8

Prices & availability of common medicines at six sites in India using a standard methodology.

Kotwani A, Ewen M, Dey D, Iyer S, Lakshmi PK, Patel A, Raman K, Singhal GL, Thawani V, Tripathi S, Laing R. Kotwani A, et al. Indian J Med Res. 2007 May;125(5):645-54. Indian J Med Res. 2007. PMID: 17642500 Free article.

9

Examining the production costs of antiretroviral drugs.

Pinheiro E, Vasan A, Kim JY, Lee E, Guimier JM, Perriens J. Pinheiro E, et al. AIDS. 2006 Aug 22;20(13):1745-52. doi: 10.1097/01.aids.0000242821.67001.65. AIDS. 2006. PMID: 16931939

10

Use of generic antiretroviral agents and cost savings in PEPFAR treatment programs.

Holmes CB, Coggin W, Jamieson D, Mihm H, Granich R, Savio P, Hope M, Ryan C, Moloney-Kitts M, Goosby EP, Dybul M. Holmes CB, et al. JAMA. 2010 Jul 21;304(3):313-20. doi: 10.1001/jama.2010.993. JAMA. 2010. PMID: 20639565

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

273 results

Results by year